Literature DB >> 3080387

Hypofractionated radiotherapy for sarcomas.

M A Ashby, C T Ago, C L Harmer.   

Abstract

In an effort to improve local control in the radiation treatment of sarcomas, up to 7 weekly fractions of 6.6 Gy each were administered to 64 patients. They were divided into two groups: Group A consisted of 37 patients with measurable disease who achieved a partial response rate of 22%, with no complete responses. Group B consisted of 27 postoperative patients with varying degrees of completeness of surgical excision, two have relapsed locally to date. Early radiation damage was documented in 26%, but was not a dose-limiting or incapacitating event in any case. Late normal tissue damage occurred in 23 out of 32 evaluable patients (72% of those at risk), and was a cause of serious morbidity in 6 patients. Response rates were low in Group A compared with other series, but in Group B the local recurrence rate is comparable with other centers using "conventional" fractionation. No apparent improvement in therapeutic gain was demonstrated for large weekly fractions.

Entities:  

Mesh:

Year:  1986        PMID: 3080387     DOI: 10.1016/0360-3016(86)90409-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Head and neck sarcomas: prognostic factors and implications for treatment.

Authors:  R A Eeles; C Fisher; R P A'Hern; M Robinson; P Rhys-Evans; J M Henk; D Archer; C L Harmer
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

Review 2.  Radiation oncology in times of COVID-2019: A review article for those in the eye of the storm - An Indian perspective.

Authors:  Ritika Harjani Hinduja; Karishma George; Mansi Barthwal; Vibhay Pareek
Journal:  Semin Oncol       Date:  2020-07-13       Impact factor: 4.929

3.  Patterns of Practice Survey: Radiotherapy for Soft Tissue Sarcoma of the Extremities.

Authors:  Chan-Kyung J Cho; Charles Catton; Caroline L Holloway; Karen Goddard
Journal:  Cureus       Date:  2019-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.